Current perspectives on recurrent HPV-mediated oropharyngeal cancer

Current perspectives on recurrent HPV-mediated oropharyngeal cancer

In the recent years, the prevalence of HPV-positive oropharyngeal squamous cell carcinoma (OPSCC) has increased significantly. Currently, nearly 80-90% of all oropharynx tumors are HPV-positive. In addition, it is now recognized that HPV-positive tumor status is associated with good prognosis and im...

Full description

Bibliographic Details
Main Authors:	Theresa Guo, Stephen Y. Kang, Ezra E. W. Cohen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Series:	Frontiers in Oncology
Subjects:	oropharyngeal cancer (OPSCC) recurrent disease surgical salvage immunotherapy human papillomavirus (HPV) head neck squamous carcinoma
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.966899/full

Similar Items

The Lack of Standardized Outcomes for Surgical Salvage of HPV-Positive Recurrent Oropharyngeal Squamous Cell Carcinoma: A Systematic Scoping Review
by: April N. Taniguchi, et al.
Published: (2023-05-01)

The Impact of Human Papillomavirus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma (OPSCC) on Nutritional Outcomes
by: Jane Harrowfield, et al.
Published: (2021-02-01)

Human Papillomavirus Detected in Oropharyngeal Cancers from Chilean Subjects
by: Carolina Oliva, et al.
Published: (2022-06-01)

Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for the Outcome of HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma
by: Marius Meldgaard Justesen, et al.
Published: (2023-01-01)

Is High-Risk Sexual Behavior a Risk Factor for Oropharyngeal Cancer?
by: Gunnar Wichmann, et al.
Published: (2023-06-01)

Long-Term Survival and Recurrence in Oropharyngeal Squamous Cell Carcinoma in Relation to Subsites, HPV, and p16-Status
by: Malin Wendt, et al.
Published: (2021-05-01)

Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes
by: Lalida Arsa, et al.
Published: (2021-05-01)

Diagnostic Delay in HPV-Related Oropharyngeal Squamous Cell Carcinoma
by: Patrick O. McGarey, et al.
Published: (2024-01-01)

Population-based utility scores for HPV infection and oropharyngeal squamous cell carcinoma among Indigenous Australians
by: Xiangqun Ju, et al.
Published: (2021-07-01)

Updates in the management of unknown primary of the head and neck
by: Sandhya Kalavacherla, et al.
Published: (2022-09-01)

A Contemporary Systematic Review on Repartition of HPV-Positivity in Oropharyngeal Cancer Worldwide
by: Amanda F. Carlander, et al.
Published: (2021-07-01)

High-Risk Human Papillomavirus (HR-HPV) DNA Detection in Mouthwashes for Diagnosis of HPV-Driven Oropharynx Cancer and Its Curative Therapy—A Feasibility Study
by: Gera Loermann, et al.
Published: (2022-09-01)

Sex-specific aspects in patients with oropharyngeal squamous cell carcinoma: a bicentric cohort study
by: Charlotte Klasen, et al.
Published: (2023-11-01)

Influence of sex on survival rates of HPV-positive oropharyngeal cancers
by: Sally H. Preissner, et al.
Published: (2022-08-01)

Outcome differences in HPV-driven head and neck squamous cell carcinoma attributable to altered human leukocyte antigen frequencies
by: Gunnar Wichmann, et al.
Published: (2023-12-01)

Surgical clinical trials for HPV-positive oropharyngeal carcinoma
by: Chen Lin, et al.
Published: (2022-11-01)

CD8+ T Cells and PD-L1 Expression as Prognostic Indicators in a Low Prevalence of HPV-Associated Oropharyngeal Squamous Cell Carcinoma
by: Kawita Atipas, et al.
Published: (2023-01-01)

Changes in the Incidence and Human Papillomavirus-Positive Portion of Oropharyngeal Squamous Cell Carcinoma in Hong Kong
by: Zigui Chen, et al.
Published: (2024-01-01)

An Update on the Immunotherapy for Oropharyngeal Squamous Cell Carcinoma
by: Yaxuan Huang, et al.
Published: (2022-03-01)

Enhanced Radiation Sensitivity of Human Papillomavirus-Driven Head and Neck Cancer: Focus on Immunological Aspects
by: Mine Özcan-Wahlbrink, et al.
Published: (2019-12-01)

Recent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck Cancer
by: Sonia N. Whang, et al.
Published: (2015-09-01)

The relation between human papillomavirus (HPV) and oropharyngeal cancer: a review
by: Chrystiano Campos Ferreira
Published: (2023-06-01)

The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naïve tumors with immune checkpoint inhibitors
by: Anna Tosi, et al.
Published: (2022-09-01)

A Mouse Model of Oropharyngeal Papillomavirus-Induced Neoplasia Using Novel Tools for Infection and Nasal Anesthesia
by: Andrea Bilger, et al.
Published: (2020-04-01)

Genetic Mutations Associated with Inflammatory Response Caused by HPV Integration in Oropharyngeal Squamous Cell Carcinoma
by: Mai Atique, et al.
Published: (2023-12-01)

Genotype Distribution and Prevalence of Human Papillomavirus in Head and Neck Cancer Samples from Istanbul, Turkey
by: Muammer Osman Köksal, et al.
Published: (2021-11-01)

Toxicity Reduction in the Treatment of HPV Positive Oropharyngeal Cancer: Emerging Combined Modality Approaches
by: Sarah Deschuymer, et al.
Published: (2018-10-01)

Level IV neck dissection in cN0 HPV-negative oropharyngeal squamous cell carcinoma: a retrospective cohort study
by: Zirong Huo, et al.
Published: (2022-05-01)

Predictors for Survival of Patients with Squamous Cell Carcinoma of Unknown Primary in the Head and Neck Region
by: Steffen Wagner, et al.
Published: (2023-04-01)

The Use of HPV16-E5, EGFR, and pEGFR as Prognostic Biomarkers for Oropharyngeal Cancer Patients
by: Miren Taberna, et al.
Published: (2018-12-01)

Post-Treatment HPV Surface Brushings and Risk of Relapse in Oropharyngeal Carcinoma
by: Barbara Kofler, et al.
Published: (2020-04-01)

Whole-Exome Sequencing of HPV Positive Tonsillar and Base of Tongue Squamous Cell Carcinomas Reveals a Global Mutational Pattern along with Relapse-Specific Somatic Variants
by: Andreas Ährlund-Richter, et al.
Published: (2021-12-01)

Human Papilloma Virus (HPV) driven oropharyngeal cancer in current or previous heavy smokers: should we look for a different treatment paradigm?
by: Luigi Lorini, et al.
Published: (2024-04-01)

DNA Methylation and HPV-Associated Head and Neck Cancer
by: Takuya Nakagawa, et al.
Published: (2021-04-01)

Race and socioeconomic status interact with HPV to influence survival disparities in oropharyngeal squamous cell carcinoma
by: Emily Z. Yan, et al.
Published: (2023-04-01)

The Effect of Prophylactic HPV Vaccines on Oral and Oropharyngeal HPV Infection—A Systematic Review
by: Kristoffer Juul Nielsen, et al.
Published: (2021-07-01)

De-Escalation Strategies of (Chemo)Radiation for Head-and-Neck Squamous Cell Cancers—HPV and Beyond
by: Alexander Rühle, et al.
Published: (2021-05-01)

The Role of HPV in Determining Treatment, Survival, and Prognosis of Head and Neck Squamous Cell Carcinoma
by: Imogen Sharkey Ochoa, et al.
Published: (2022-09-01)

Editorial: Considerations in the surgical management of HPV-positive oropharyngeal squamous cell carcinoma
by: Jon Mallen-St Clair, et al.
Published: (2023-06-01)

Role of DNA Methylation Profiles as Potential Biomarkers and Novel Therapeutic Targets in Head and Neck Cancer
by: Kyunghee Burkitt
Published: (2023-09-01)